Gian Paolo Caviglia
Overview
Explore the profile of Gian Paolo Caviglia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tovo P, Ribaldone D, Caviglia G, Calvi C, Montanari P, Tizzani M, et al.
Cells
. 2025 Feb;
14(3).
PMID: 39936987
Irritable bowel syndrome (IBS) is a common disease, whose etiopathogenesis is poorly understood. Human endogenous retroviruses (HERVs) originate from ancient infections of germinal cells and represent 8% of our DNA....
2.
Zaccardi B, Armandi A, Caviglia G, Broglio F, Vernero M, Bombonato M, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797226
The characterization of patients with inflammatory bowel disease (IBD) and type 2 diabetes mellitus (T2DM) as a new group has not been well detailed. This study aimed to evaluate the...
3.
Caviglia G, DAmbrosio R, Colombatto P, Ciancio A
Aliment Pharmacol Ther
. 2024 Dec;
61(3):585-586.
PMID: 39723756
No abstract available.
4.
Cusato J, Ribaldone D, D Avolio A, Infusino V, Antonucci M, Caviglia G, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685734
: Vitamin D (VD) has immunoregulatory properties, generating interest in its potential to influence therapeutic outcomes in inflammatory bowel disease (IBD), other than affecting the expression of genes encoding enzymes...
5.
Armandi A, Rosso C, Caviglia G, Bugianesi E
Metabolism
. 2024 Nov;
162:156080.
PMID: 39571891
Hepatocellular carcinoma (HCC) is a relevant complication occurring in individuals with advanced Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). Recent epidemiological data suggest an alarming increase in the HCC burden worldwide,...
6.
Caviglia G, Fariselli P, DAmbrosio R, Colombatto P, Degasperi E, Ricco G, et al.
Aliment Pharmacol Ther
. 2024 Nov;
61(3):538-549.
PMID: 39569574
Background And Aims: Patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAA) remain at risk of developing hepatocellular carcinoma (HCC). Recently, serum protein...
7.
Tovo P, Ribaldone D, Galliano I, Caviglia G, Dini M, Veglio V, et al.
Viruses
. 2024 Oct;
16(10).
PMID: 39459904
Inflammatory bowel disease (IBD) includes patients affected by Crohn's disease or ulcerative colitis. IBD is thought to be a chronic immune-mediated disease, but its origin remains elusive, and this limits...
8.
Ammirata G, Arigoni M, Licastro D, Caviglia G, Disabato M, Zubair G, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334706
The relationship between serum 25-hydroxyvitamin D (25(OH)D) levels, genomic response to vitamin D (Vit.D), and positivity to SARS-CoV-2 remains understudied. In this pilot study, during the follow-up of patients with...
9.
Caviglia G, Casalone E, Olivero A, Birolo G, Ciancio A, Matullo G, et al.
J Viral Hepat
. 2024 Aug;
31(11):771-774.
PMID: 39129189
Micro-RNAs (miRNAs) are involved in the modulation of viral replication and host immune antiviral response. Using next-generation sequencing, we investigated the miRNome profile of circulating extracellular vesicles in 20 patients...
10.
Castelnuovo G, Perez-Diaz-Del-Campo N, Rosso C, Armandi A, Caviglia G, Bugianesi E
Nutrients
. 2024 Jul;
16(13).
PMID: 38999775
Plant-based diets (PBDs) are gaining attention as a sustainable and health-conscious alternative for managing various chronic conditions, including metabolic dysfunction-associated steatotic liver disease (MASLD). In the absence of pharmacological treatments,...